
Temozolomide is an oral chemotherapy medicine used to treat certain malignant brain tumours, including glioblastoma and anaplastic astrocytoma. It may be prescribed with radiotherapy or used alone under an oncologist’s supervision.
| Generic Name | Temozolomide |
| Strength | 100 mg |
| Manufacturer | Dr. Reddy’s Laboratories Ltd. |
| Packing | 100 mg |
| Prescribed For | Treat malignant brain tumors |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




| Package | USD | GBP | AUD | NZD | PHP | KRW | RON | HKD | MYR | THB | AED |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5 Capsules | $70 | £52 | A$98 | NZ$122 | ₱4,383 | ₩94,465 | lei 319 | HK$549 | RM285 | ฿2,287 | د.إ257 |
Temozolomide changes into an active compound after entering the body. This compound attaches chemical groups to the DNA of cancer cells, damaging their genetic material and preventing them from growing and dividing. The damaged cells eventually die, helping slow the growth of certain brain tumours.
Temozolomide prices may vary between countries depending on the brand, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement, regulatory or medicine information.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.